Journal of Hematology & Oncology

Editor-in-Chief

Delong Liu, New York Medical College

Editorial Board | Instructions for authors | FAQ

Society Affiliations

Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.

Articles

There has been an error retrieving the data. Please try again.

Review

Novel therapeutic agents for cutaneous T-Cell lymphoma

Jain S, Zain J and O'Connor O Journal of Hematology & Oncology 2012, 5:24 (17 May 2012)
Short report

Pharmacokinetics of Dasatinib for Philadelphia- Positive Acute Lymphocytic Leukemia with Acquired T315I mutation

Takahashi N, Miura M, Scott SA, Niioka T and Sawada K Journal of Hematology & Oncology 2012, 5:23 (15 May 2012)
Rapid communication

The significance of low PU.1 expression in patients with acute promyelocytic leukemia

Zhu X, Zhang H, Qian M, Zhao X, Yang W, Wang P, Zhang J and Wang K Journal of Hematology & Oncology 2012, 5:22 (8 May 2012)
Review

Recent advances and novel agents for gastrointestinal stromal tumor (GIST)

Lamb G, Ambrale S, Lee B, Gupta R, Rafiyath SM and Liu D Journal of Hematology & Oncology 2012, 5:21 (8 May 2012)
Research

Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome

Galili N, Tamayo P, Botvinnik OB, Mesirov JP, Brooks MR, Brown G and Raza A Journal of Hematology & Oncology 2012, 5:20 (6 May 2012)
Review

Clinical applications of mesenchymal stem cells

Wang S, Qu X and Zhao RC Journal of Hematology & Oncology 2012, 5:19 (30 April 2012)
Research

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)

Raza A, Galili N, Mulford D, Smith SE, Brown G, Steensma DP, Lyons RM, Boccia R et al. Journal of Hematology & Oncology 2012, 5:18 (30 April 2012)
Research

Deprivation of arginine by recombinant human arginase in prostate cancer cells

Hsueh EC, Knebel SM, Lo WH, Leung YC, Cheng PNM and Hsueh CT Journal of Hematology & Oncology 2012, 5:17 (30 April 2012)
Research

Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells

Hu C, Huang L, Gest C, Xi X, Janin A, Soria C, Li H and Lu H Journal of Hematology & Oncology 2012, 5:16 (25 April 2012)
View more articles

RSS

Comments

Erratum

Comment on: Javle et al. Journal of Hematology & Oncology 2009, 2:9

Aims & scope

Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology.

Latest Review

Novel therapeutic agents for cutaneous T-Cell lymphoma

Jain S, Zain J and O'Connor O

Journal of Hematology & Oncology 2012, 5:24 (17 May 2012)

Abstract | Provisional PDF

Latest supplements

Volume 5 Suppl 1 (25 April 2012)

New developments in Hematology and Oncology in 2011

Meeting abstracts
Guangzhou, China. 25-26 December 2011

Submit a manuscript Register Follow us on

Indexed by

CAS
Current contents
Embase
Google Scholar
MEDLINE
PubMed
PubMed Central
Science Citation Index Expanded
Scopus

View all

ISSN: 1756-8722